Nicholas Kian Mollanazar, MD, MBA

he/him/his
Dermatology
Accepting new patients
Sees patients age 18 and up
Penn Dermatology Perelman
Schedule onlineCall 215-662-2737
Penn Medicine Provider

About me

  • Co-Chair, Electronic Medical Record Governance, Department of Dermatology
  • Director, Dermatology Patient Access
  • Applied Informatics Specialist, Dermatology
  • Assistant Professor of Clinical Dermatology

My education and training

  • Medical School: Temple University
  • Residency: Pennsylvania Hospital
  • Residency: Temple University Hospital

Spoken languages

English
English

Reviews

Average Rating

2033 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

Anonymous
May 2026
efficient and polite
Anonymous
May 2026
i was satified
Anonymous
May 2026
knowledge
Anonymous
May 2026
great personality and comfortable to deal with

Insurance accepted

Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.

Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Mollanazar is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

Research

Publications

Alomary SA, Baker NJ, Taylor SC, Mollanazar NK Enhancing Dermatology Workflow Through a Replicable Epic-Based Module: Impact on Documentation and After-Hours EMR Use , J Am Acad Dermatol: 2026,S0190-9622(26)00467

Anusionwu I, Puerta Durango K, Barrera TM, Ogunleye T, Taylor SC, Mollanazar NK The Prevalence of Dupilumab-Associated Adverse Events Among Black and African American Adult Patients with Atopic Dermatitis: A Retrospective Chart Review , J Drugs Dermatol, 24(10): 2025,1054-55

Ruiz Dasilva D, Soto-González A, Mollanazar NK, Ndubisi S, Issa N, Song JE, Shahriari M, Bunick CG, Lio P, Nguyen HP, Yosipovitch G, Del Rosso J Nemolizumab Demonstrates Marked Efficacy in Challenging Chronic Pruritus: A Real-world Multicenter Case Series , J Clin Aesthet Dermatol, 18(9): 2025,40-46

Mollanazar N, Doran J, Nguyen T, Pivneva I, Signorovitch J, Sullivan R, Voegel A, Uritsky T, et al Delayed biologic initiation is associated with increased healthcare resource use in patients diagnosed with hidradenitis suppurativa , Journal of the American Academy of Dermatology, 93(3): 2025,AB163

Kwatra SG, Pereira MP, Misery L, Mollanazar NK, Shah P, Wiggins S Prurigo nodularis: disease burden, clinical features and approach to management , Br J Dermatol, 193(4): 2025,642-52

Mollanazar N, Isaman DL, Wiggins S, Sivamani RK, Chih-Ho Hong H, Chovatiya R, Yu T, Zahn J, Petruski-Ivleva N, Bosman K, et al: Real-World Medication Use Prior to Dupilumab Initiation Among Adult Patients With Prurigo Nodularis in the US , Journal of the American Academy of Dermatology, 93(3): 2025,AB285

Anusionwu I, Puerta Durango K, Barrera TM, Ogunleye T, Taylor SC, Mollanazar N The Prevalence of Dupilumab-Associated Adverse Events Among Black and African American Adult Patients with Atopic Dermatitis: A Retrospective Chart Review , J Drugs Dermatol, 24(8): 2025,8749

Mehta A, Perry N, Encarnacion I, Mollanazar N, Taylor SC Disparities in Alopecia Areata and Vitiligo FDA-Approved Therapies in Medicaid Formularies , J Drugs Dermatol, 24(3): 2025,e17

Ruiz Dasilva D, Desir N, Encarnacion IN, Issa N, Song EJ, Mollanazar NK Achievement of Optimal Treatment Targets with Oral Janus Kinase Inhibition in Elderly Patients with Atopic Dermatitis: A Real-world, Multicenter, Retrospective Study , J Clin Aesthet Dermatol, 18(2): 2025,25-29

Butler DC, Berger T, Elmariah S, Kim B, Chisolm S, Kwatra SG, Mollanazar N, Yosipovitch G Chronic Pruritus: A Review , JAMA, 331(24): 2024,2114 - 24

View all publications